Cytokines are an important class of proteins responsible for intercellular communication. The helical cytokines have a four-helix bundle fold, and they have remained largely intractable for sequence alignment methods due to their high evolutionary divergence. This paper presents a method that is specifically designed to recognize the helical cytokine fold in preprotein sequences such as full-length cDNA translations or transcripts predicted by gene finding methods. A protein fold is modeled by multiple sequence profiles, each representing a structurally conserved region. Nonstructural profiles are used to represent additional signals found in preprotein sequences. Profiles are connected by loop regions, each of a specified minimum and maximum length. A model for the helical cytokines is created by progressively improving a placement of four amphipathic helices onto training sequences. The sensitivity and specificity of the method are evaluated by a cross-validation procedure, demonstrating that cytokines with no intrafamily sequence similarity can be recognized. The method has been successfully used for the discovery of several new helical cytokines in the human genome.
INTRODUCTION C
ytokines are an important class of proteins responsible for intercellular communication. Through binding to specific cell surface receptors, they initiate the signals that are critical for cell proliferation, differentiation, and apoptosis. They fall into a small number of structural classes, including the beta-trefoil factors, the cysteine knot growth factors, the tumor necrosis factor family, and the four-helix bundle or helical cytokines.
Several helical cytokines are used as biopharmaceuticals for the treatment of human disease: interferon alpha (hepatitis); interferon beta (multiple sclerosis); granulocyte colony stimulating factor (neutropenia or white blood cell deficiency); erythropoietin (anemia or red blood cell deficiency); somatotropin (growth hormone deficiency); interleukin-2 (cancer); granulocyte macrophage colony stimulating factor (bone marrow transplantation); interleukin-11 (thrombocytopenia or platelet cell deficiency); and interferon gamma (osteopetrosis). Thus, there is great interest in recognizing new helical cytokines in the human genome.
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CONKLIN
Fold recognition is the process of predicting the structure of a sequence by recognizing whether it is compatible with any known structures in a library. Due to the high evolutionary divergence of the helical cytokines, they have remained largely intractable for fold recognition methods. This paper presents a new method that is specifically designed to recognize the helical cytokine fold in preprotein sequences (those containing N-terminal secretory signal sequences), such as full-length cDNA translations or transcripts predicted by gene finding methods. It is rigorously evaluated using a cross-validation procedure which tests whether known cytokines could be recognized if they had not been included in the training set of sequences. The method achieves high overall specificity and recognizes several cytokines that have no intrafamily sequence similarity. It has been successfully used for the discovery of several new helical cytokines in the human genome.
Fold recognition review
The most reliable method for predicting the structure of a sequence is by alignment with sequences of proteins whose 3D structure is known. This relies on the fact that significantly high alignment scores usually indicate structural similarity. In the twilight zone of sequence similarity, however, an alignment score is equally likely to be observed between structurally unrelated sequences. For more sensitive prediction of protein structure, various types of fold recognition methods have been proposed.
Threading methods (Jones et al., 1992) attempt to optimally align residues of a sequence onto core regions of a known structure, scoring the alignment with an empirical pseudo-energy function. This function involves pairwise and higher-order interaction terms applied to residues that are in contact in the structure (Bryant and Lawrence, 1993 ). An early promising success of a threading method was the prediction of the leptin hormone as a helical cytokine (Madej et al., 1995) . Despite their power and generality, threading methods can be computationally intractable due to the presence of interaction terms; therefore, almost all threading methods use some form of optimization algorithm and cannot guarantee the computation of the best structure to sequence alignment. Due to their heavy dependence on interaction terms, they will fail if the true structure of the sequence and the closest library structure diverge to the point of breaking or adding many contacts between residues.
The 3D profile method (Bowie et al., 1991) converts a structure into a sequence of environment descriptors, each describing the solvent accessibility and polarity of each residue. A sequence is aligned to an environment descriptor sequence, using a scoring matrix that provides the empirically derived scores for the compatibility of residues with different environments. This step is repeated for each derived environment descriptor sequence in the library. Since interaction terms are not explicitly represented, the 3D profile method can apply efficient dynamic programming for the computation of sequence to structure alignments.
Sequence profiles (Gribskov et al., 1987; Luthy et al., 1994; Altschul et al., 1997; Kelley et al., 2000) and the related hidden Markov models (Krogh et al., 1994; Eddy, 1998) use multiple alignments of homologous sequences to create generalized models. Sequence profiles extend the sensitivity of sequence alignment methods, but they rapidly lose specificity with increasing evolutionary divergence. This is because accurate multiple sequence alignment becomes problematic and non-conserved loop regions will introduce noise into a profile. A straightforward yet powerful variant of the basic profile method uses multiple ungapped profiles, each representing a structurally conserved region. Each individual profile alone may have only weak specificity, but collective specificity emerges from the combined effect of multiple profiles. The use of multiple sequence profiles for structurally conserved regions, sometimes with permitted spacing between them, has been applied by many groups (Taylor, 1998; Bailey and Gribskov, 1998; Grundy et al., 1997; Neuwald et al., 1997; Hudak and McClure, 1999) . They have been generally referred to as motif models (Eddy, 1998) .
In practice there is substantial overlap between different fold recognition methods, and techniques have been developed that try to approximate threading algorithms without inheriting their computational complexity. For example, the 3D profile method described above can be augmented by subsequent rescoring of initial alignments with pairwise interaction terms (Johnson et al., 1996) . Alternatively, alignments computed by sensitive profile or sequence alignment methods can be evaluated using a pseudo-energy function (Jones, 1999) . These methods rely on the fast computation of a possibly suboptimal alignment on which pairwise interactions are evaluated. Threading methods can be augmented with multiple alignment information by using profiles for each core region, evaluating alignments using a combination of profile and interaction terms (Panchenko et al., 2000) . (Feng et al., 1996) ; image generated by MOLSCRIPT (Kraulis, 1991) . IL3 has a short additional helix in the A to B loop. The view is into the inner core of the helix bundle; helix A is in the upper right corner, and the additional helix A at the bottom. In most other short-chain cytokines, the C to D loop is on the outside of the A to B loop. Right: helical hydrophobic moment plot [N = 15, δ = 100 • , GES (Engelman et al., 1986) hydropathy scale] of the IL3 preprotein sequence, with the actual location of helices in horizontal bars.
Structure and classification of the helical cytokines
The biologically active form of a helical cytokine is a soluble protein with a helical bundle fold (Fig. 1) . Crystal structure studies of various helical cytokines have illustrated an intriguing variety of oligomeric forms; as monomers, as covalent or noncovalent homodimers, or as heterodimeric complexes with a soluble receptor chain. The homodimers of some helical cytokines are inter-digitated, with one monomer contributing a helix to the helical bundle of the other monomer.
The structurally conserved core of the fold comprises four helices, by convention labeled A through D, in a four-helix bundle. As with all soluble helical bundle proteins, the helices are amphipathic, having a solvent-facing hydrophilic side and a buried hydrophobic side. The four helices are oriented in an up-updown-down topology (Presnell and Cohen, 1989) ; among all four-helix bundle folds in the Protein Data Bank, this topology is still unique to the helical cytokines. The helices and their connecting loops vary widely in length among family members. Due to this substantial intrafamily structural divergence, the helical cytokines are usually subclassified into short-chain, long-chain, and interferon groups (Rozwarski et al., 1994) based on their sequence length, the presence of additional short secondary structural elements within the loop regions, and the topology of the helix C to D loop. This classification is not fully adequate, however, because structural studies have shown that some cytokines share properties of more than one class (e.g., IL3: Fig. 1) . A more biologically motivated classification of the helical cytokines is according to the type of receptor they bind and the signaling pathway employed (Vosshenrich and Di Santo, 2002) .
In this study, no distinction is made between short-chain, long-chain, and interferon groups. Instead, the helical cytokines are classified based on the general structure of their preprotein sequence (Fig. 2) . Group 1 cytokines have an N-terminal signal sequence and no substantial C-terminal extension following the D helix. The signal sequence is released cotranslationally in the endoplasmic reticulum by a signal peptidase and is not present in the mature protein. Most helical cytokines fall into this group (Table 1) . Group 2 cytokines lack a classical secretory signal sequence and are secreted from the cell by a different mechanism. Group 3 cytokines have a hydrophilic C-terminal extension, following the D helix, that is released posttranslationally by extracellular proteases. The length of the extension is about 35 residues in OSM and about 180 residues in THPO. Finally, group 4 cytokines are type I membrane proteins (i.e., with a cytoplasmic C-terminus), with a spacer region and a transmembrane domain following the D helix; these cytokines are anchored to the cell surface and are released and activated by extracellular proteases. Following the transmembrane domain, they have a short (about 35 residues) cytoplasmic extension. The group 4 cytokines are additionally unusual in that they bind to receptor tyrosine kinases and therefore signal through different pathways from all other helical cytokines. The helical cytokine model developed in this paper is intended primarily for the recognition of group 1 cytokines.
Evolutionary divergence of the family
An established fact of molecular evolution is that protein sequences can diverge substantially while retaining similar structures. The helical cytokines form a superfamily: a divergent group of evolutionarily related proteins (henceforth, the terms superfamily and family will be used interchangeably). Evidence of evolutionary relationships in this family is in their conserved structure, similarities in exon-intron boundaries (Bazan, 1990; Betts et al., 2001) , and broadly similar receptor families (Vosshenrich and Di Santo, 2002; Boulay et al., 2003) . The family has diverged to the point that pairwise sequence alignment techniques cannot detect similarities between many family members. More sophisticated fold recognition methods have also had limited success with the helical cytokines (Hill et al., 2002; Rozwarski et al., 1994; Jones, 1999; Kelley et al., 2000) .
Despite its sequence divergence, the helical cytokine fold has an amphipathic structure with a hydrophobic inner core. This amphipathic structure produces a hydrophobic periodicity in the sequence that can be visualized on a helical hydrophobic moment plot (Eisenberg et al., 1984) , where a rough correspondence of peaks with the N-termini of amphipathic helices can often be seen (Fig. 1) . However, the hydrophobic moment method is too general to be directly applicable for fold recognition; many proteins, particularly those containing the ubiquitous coiled-coil motif, have extended amphipathic helices. In addition, in the helical cytokines, polar residues can occur at fully buried positions (Rozwarski et al., 1994) , reducing the prominence of peaks in a hydrophobic moment plot. Nevertheless, the recognition of general amphipathic structure provides a starting point for a more powerful model, as described in Section 4: Methods.
RESULTS
For a complete description of the theory and methods used for fold recognition of the helical cytokines, the reader is referred to Section 4.
The training sequences
A collection of 44 human helical cytokine sequences (Table 1) was used to create a motif model for fold recognition. Though the model is intended primarily for group 1 cytokines, to augment the amount of data available for model creation, all non-group 1 sequences were prepared for inclusion in the training set by appropriate trimming (groups 3, 4) or adding a signal sequence (group 2). Specifically, CSF1 was trimmed according to its PDB entry 1HMC; KITLG was trimmed at its exon 5-6 junction; and OSM and THPO were trimmed by removing their C-terminal hydrophilic portion. The signal sequence and cleavage site of IL10 was added to the N-terminus of CNTF and CTF1. The group 1 rather than the group 4 isoform of FLT3LG was included. Though the method uses sequence weights to avoid biases introduced by homologous sequences, a few nearly identical sequences in the family were not included in the training 
CONKLIN FIG. 3.
Cross-validated sensitivity and specificity of the fold recognition method for helical cytokines. Sensitivity and specificity for searching human sequences in Swiss-Prot using ablated models are plotted against score. Genes in bold cannot be recognized as helical cytokines by BLAST; those in italics can be recognized but have less than 30% identity to their closest family member in the training set.
set: for example, the various interferon alpha homologs; the somatotropin homologs GH2, CSH1, CSH2, and CSHL1. Figure 3 illustrates the ability of the gapped BLAST (Altschul et al., 1997) method to recognize helical cytokines. Each training sequence was used as a query against the training database with the parameters Z=250e6 (to simulate a large database size) and E=10 (a permissive E-value threshold). Those queries that do not contain another helical cytokine in their BLAST output are noted in Fig. 3 . It is apparent that many cytokines have no significant sequence similarity to other family members.
Evaluation of the method
A leave-one-out cross-validation procedure was used for evaluation of the fold recognition method for helical cytokines (see Section 4.5). Each training cytokine is in turn removed from the full training set, a model is created from the remaining training sequences, and the ablated model is applied to all human proteins in the Swiss-Prot database along with the full training set. Figure 3 plots the sensitivity and specificity of the method against the cross-validated score for all 44 helical cytokines in the training set. From the plot, approximate thresholds can be calibrated for subsequent database searches. For a 100% sensitive (and roughly 73% specific) search, a cutoff score of about 22 (the cross-validated score of IL9) is used for subsequent database searches.
The specificity curve of Fig. 3 provides an analyst with an estimate of the probability of a sequence with a given score to be a true cytokine, for scores above the 100% sensitivity threshold. Cytokines with no intrafamily similarity and a probability near 100% best illustrate the excellent performance of the method.
Examples of this include the leptin hormone LEP as well as other divergent cytokines, such as LIF, CSF3, IL7, IL12A, OSM, IL6, IL2, IL4, IL5, IL31, and KITLG. These have at most one false positive (VT1A: see below) above their cross-validated score. Interestingly, several cytokines with significant intrafamily similarity have a probability less than 100%. This indicates that the model is not overfitting the training data and supports its overall good performance.
There are some recurrent false positives in the Swiss-Prot database that prevent the method from achieving higher accuracy during cross-validation. The five highest-scoring noncytokine sequences encountered are v-SNARE protein (sp:VT1A_HUMAN, score 31.7), BCR-associated protein (sp:BA29_HUMAN, 27.1), caspase-14 (sp:ICEE_HUMAN, 26.0), BH3 interacting domain death agonist (sp:BID_HUMAN, 25.5), and tumor protein D52 (sp:TD52_HUMAN, 25.1). It is conceivable that filters or decoy models could remove these false positives while preserving the accuracy of the method. For example, none of these proteins are annotated in Swiss-Prot as being secreted, and a more accurate signal sequence prediction method could be employed. A coiled-coil decoy model could perhaps remove VT1A, and a transmembrane domain filter could remove BA29, which is annotated in Swiss-Prot as being a membrane protein. Future research will explore the use of filters and decoy motif models.
Recognition of new human helical cytokines
The method described in this paper has been successfully used for the discovery of human helical cytokines within expressed sequence tag (EST) databases, transcripts predicted by gene finding methods, and open reading frames in cDNA sequences. It was applied for the discovery of IL20, IL21, IL27, IL28A/IL29, and IL31.
The method was used to identify the helical cytokine structure of the IL28A and IL29 genes (Sheppard et al., 2003) . These genes were initially identified in a screen of a database of GENSCAN (Burge and Karlin, 1997) predicted peptides from the human genome using a signal sequence profile (von Heijne, 1986) . Their potential to fold as helical bundle cytokines was subsequently revealed through the application of the method presented here (cross-validated scores when IL28A/IL29 are both left out of the training set: 23.2/25.1; between 80% and 90% probability). The discovery of their receptor (Sheppard et al., 2003) , having sequence similarity to the IL22 receptor alpha chain, strongly supported the conclusion that they have a helical cytokine fold.
The method was used to verify the helical cytokine structure of two novel genes recently discovered by expression cloning: IL21 and IL31. The IL21 cytokine was identified by functional cloning using a proliferation assay with cells expressing the IL21R orphan receptor (Parrish-Novak et al., 2000) . To add further support to the functional cloning result and the weak IL15 homology, the method described in this paper was applied to the full-length cloned cDNA and predicted with probability near 100% that the fold of IL21 was a helical cytokine (Fig. 3) . The IL31 cytokine was identified by expression cloning using BaF3 cells expressing orphan cytokine receptor chains (Dillon et al., 2004) . IL31 cannot be recognized by BLAST as a helical cytokine (Fig. 3) . The method predicted the helical cytokine fold of IL31 with a probability of 100% (Fig. 3) .
The method has also been used to scan ESTs, or partial cDNA sequences of transcripts, for new cytokines. Since the sequences were partial and could not be expected to be aligned to the complete helical cytokine model, a truncated model was constructed by removing the helix B, C, D, and Stop profiles. This model, comprising only the methionine, signal sequence, and helix A profiles (with permitted spacing between them), was applied to a database of several million ESTs (Incyte Genomics, Inc.). An EST with one of the highest scores in the complete database was identified. This EST was 253 bp in length, had 44 bp of 5 untranslated region, a 3 end terminating in the loop between helices A and B, and no indel sequencing errors. The cDNA clone for this EST was sequenced, and in this way the new cytokine IL20 was discovered (Blumberg et al., 2001) .
The IL27 cytokine was recently discovered in EST databases by computational methods using a sequence profile designed to the helix D region of a set of long-chain helical cytokines (Pflanz et al., 2002) . The method described in this paper independently discovered this cytokine (deposited as GenBank:AX255038) within a database of GENSCAN predicted peptides with a high probability (Fig. 3) . The predicted peptide for this gene was subsequently shown to be incorrect, with a wrong first exon and a missing third exon, though it was similar enough to the true preprotein sequence to not affect the score to the helical cytokine model. This is because the first exon contained only the initiating methionine and the third exon was completely contained within the loop between helices A and B. Fortunately, the missing third exon is short (33 residues), and the helix A to B loop length without this exon was still within the permitted range.
DISCUSSION
The method described in this paper was developed for fold recognition of the group 1 helical cytokines. It uses structurally conserved regions to describe the fold and creates a plausible initial alignment of these amphipathic helices to the cytokines. The method uses 3D structural information during model creation by constraining core helix profiles to lie within known helical regions in some training sequences. Loop regions are ignored, other than to constrain their length to a specified range. Nonstructural profiles, such as the signal sequence, add important information for the recognition of preprotein sequences.
A related study, which was a motivation for the development of this method, was the work of Rozwarski et al. (1994) . They prepared a multiple structural alignment of short-chain cytokines and created ungapped profiles for core helices. Their method was not evaluated on the ability to accurately classify helical cytokines, but rather on the ability to align helices at correct positions and phases in known cytokines. They concluded that fold recognition for the helical cytokines was intractable because of the high level of evolutionary divergence. The different conclusion reached here is partially based on the more powerful model and partially on the larger collection of known helical cytokines now available to create a model.
A few recent gene discovery papers have reported on putative new helical cytokines. For example, two recent papers describe putative short-chain helical cytokines. Neither protein has intrafamily sequence similarity, but both have four exons with an exon-intron boundary structure identical to that of IL2 and several other helical cytokines, supporting a possible evolutionary relationship. The first protein, TSLP (Reche et al., 2001 ) (tre:Q969D9), binds to the IL7 receptor alpha chain and stimulates myeloid cells. This sequence is buried in the database search output of the method reported here, with a score of 14.4 to the final model. The biological data notwithstanding, given the good performance of the method on known cytokines, it is therefore quite surprising that TSLP should be a helical cytokine. The second protein, C17 (Liu et al., 2000) (sp:C17_HUMAN), was not supported by receptor binding data but rather by secondary structure analysis using a helical hydrophobic moment plot. The C17 protein is weakly predicted by the method to be a possible helical cytokine (score 20.5, just below the 100% sensitivity threshold). Finally, a recent paper (Zhu et al., 2002) has claimed that the FAM3 protein family has a helical cytokine fold. As with the case of TSLP, the method can offer no support to this conclusion (score of sp:FA3A_HUMAN: 18.1).
In the cross-validation study, many group 1 helical cytokines that have no apparent intrafamily sequence similarity are recognized with high probability. The good performance of the method is interesting because it does not consider interactions between residues in contact; each structurally conserved region is assumed to be independent of others. Furthermore, it does not make use of alternative folds by using a library of competing models. The method is effective for the helical cytokines because the amphipathic structure and hydrophobic inner core in the four-helix bundles is conserved and can be adequately modeled by profiles assuming position independence. For fold recognition of the helical cytokines, exact alignment of helices is not critical, and a shift by one or more helix turns should not adversely affect the score of a core helix. In the short-chain helical cytokines, buried polar residues that are in contact (with a hydrogen bond between side chains) form only about 12% of inner core residues (Rozwarski et al., 1994) . There are few inner core residues that definitively require modeling of their contacts with others. By this argument, the method may not be as effective with nonhelical bundle proteins, though this hypothesis awaits further research.
METHODS

Motif model for the helical cytokines
In a motif model, a protein fold is viewed as a set of structurally conserved regions. These regions are connected by loops, each of a specified minimum and maximum length. The helical cytokines have four structurally conserved regions; helix A through D. Each is modeled by an ungapped sequence profile (Gribskov et al., 1987) , which provides a log odds score for each amino acid to each column of the profile. A profile of length 15 is used for each core helix.
In addition to the four core helices, three nonstructural profiles are used for the group 1 cytokines (see Fig. 2) ; the initiating methionine and terminating Stop (both profiles of length 1), and a profile of length 15 for a secretory signal sequence and cleavage site (von Heijne, 1986) . The signal sequence profile adds important information to the model for group 1 helical cytokines, while the loop lengths between the Stop profile and helix D, and between the methionine and signal sequence, provide important constraints on the lengths of sequences that can be aligned to the motif model.
The score of a profile to a polypeptide segment of the same length is simply the sum of amino acid scores to respective columns of the profile. To standardize scores for different profiles, with possibly different scales and background distributions, the score is converted to a p-value (Staden, 1989) which gives the probability of encountering an equal or better score in random polypeptide segments of the same length as the profile.
Aligning a sequence to a model
A valid alignment of a model to a sequence is a placement of each profile onto the sequence such that the loop lengths between aligned profiles are within the ranges permitted by the model. The score of a particular valid alignment is the sum of the negative logarithms of the p-values for each profile in the model. A large number of alignments may be valid, and the optimal one can be found using a two-stage dynamic programming algorithm. In the first stage, the score of each profile to each overlapping segment of the sequence is computed and retained. This sets up the second stage, where the optimal placement of profiles obeying the loop length constraints is computed. This can be implemented efficiently using a dynamic programming algorithm with computation time proportional to C(n− C), where n is the sequence length and C is the sum of the lengths of all profiles (C = 77 for the helical cytokine model).
The nonstructural profiles within a model have associated cut-off scores, and sequences without valid alignments meeting each cut-off score are not presented in the search output. For the signal sequence profile, a cut-off score that accepted all of the group 1 cytokines was used (this is the only model parameter that remains fixed during model evaluation by cross-validation).
Model creation
A model is created by an iterative alignment and profile creation process, similar to the maximum likelihood estimation process used by hidden Markov models (Krogh et al., 1994) . First, an initial alignment is computed for each training sequence (Section 4.4). These alignments are converted into multiple alignments for each profile. An ungapped profile is constructed for each multiple alignment by using the configuration recommended by Luthy et al. (1994) : the average score profile creation method (Gribskov et al., 1987) , using the BLOSUM45 scoring matrix (Henikoff and Henikoff, 1992 ) and a sequence weighting scheme (Henikoff and Henikoff, 1994) . This produces a new model which is aligned anew to the training sequences. These two steps of multiple alignment and model construction are repeated while the sum of all training sequence scores continues to increase. Typically, between 5 to 10 iterations suffice until a locally optimal model is found. During the iterative model creation process, loop length ranges between all profiles are ignored; for the final model each range is frozen to the minimum and maximum loop lengths observed in the final alignment to the training sequences. The signal sequence profile remains fixed and is not recomputed from multiple alignments at each iteration.
Structural information contained in the Protein Data Bank is used during model creation. For training sequences for which 3D structural information is known, a broad range spanning observed core helices is found by visual inspection of protein structures. For cases where 3D structural information is not known, it is inferred if possible by homology modeling. During model creation, core helix profiles are constrained to be placed within these identified regions.
A multiple structural alignment of the family could also have been used during model creation, to ensure that helices are synchronized in analogous regions in training sequences. However, structural superposition of short-chain to long-chain cytokines can be problematic (Hill et al., 2002) , and is further complicated by including sequences of divergent family members that do not have structural information.
Initial alignment
An important issue with all iterative model creation algorithms is the profound effect of the initial model (Krogh et al., 1994) . Since iterative algorithms provide only locally optimal solutions, arbitrary initial models generally yield poor final models. Even though structural information is used to guide the placement of helices for some cytokines (Section 4.3), the identified helical regions are wide and permit many valid alignments. Two ways to provide a rough initial placement of amphipathic helices were originally considered; the helical hydrophobic moment technique (Eisenberg et al., 1984) and a heptad amphipathic helix sequence profile (Paliakasis and Kokkinidis, 1992) , both adapted for helices of length 15. A simple hydrophobic/polar (HP) motif method was developed and found to be superior to either of these methods according to the mean cross-validated specificity (see Section 4.5). In the HP method, each residue in a segment of length 15 is scored using the GES hydropathy scale (Engelman et al., 1986) : scores of residues at relative positions 0, 3, 4, 7, 10, 11, 14 (the hydrophobic positions) are summed; scores of residues at other positions (the hydrophilic positions) are divided by 8 (the total number of hydrophilic positions) and subtracted from the total. In this way, hydrophobic residues at hydrophobic positions of the motif are rewarded, and hydrophobic residues at hydrophilic positions of the motif are weakly penalized.
To create an initial alignment, the scores of the HP motif replace those of the core helix profiles in the first iteration of the model creation algorithm (Section 4.3).
Model evaluation by cross-validation
To evaluate the performance of the fold recognition method for helical cytokines, a validation set comprising all human sequences in the Swiss-Prot database (release 42.7, December 2003) was used. There are 10,404 human sequences in this database; this can be effectively reduced to 3,379 sequences by considering only those having a signal sequence scoring above a permissive cut-off score (Section 4.2). To assess whether the method can recognize an individual cytokine, it is important that all memory of the cytokine is erased from a model. This can be accomplished using a leave-one-out cross-validation procedure: each training cytokine is in turn removed from the full training set, a model is created from the remaining training sequences, and the ablated model is applied to the validation set along with the full training set. The score of the removed cytokine in the database search output is noted, and the number of training sequences recognized (true positives: tp), noncytokines encountered (false positives: fp), and training sequences missed (false negatives: fn) at that score boundary is computed. The sensitivity ( tp tp+fn ) and specificity ( tp tp+fp ) are computed and plotted against the score of the removed cytokine (Fig. 3) .
